BPB Reports

2026 - Vol. 9 No. 6

2026 - Vol. 9

Report (Case Report)
Treatment Strategy Discussion with a Physician Using a Tracing Report Based on Personal Health Record Monitoring: A Case Report Vol.9, No.6, p.214-217
Haruka Shiokawa , Shingo Kondo , Mari Maese , Yuko Okamoto , Hiroki Iwata , Katsunori Yamaura
Received: October 21, 2026
Accepted: November 03, 2026
Released: November 12, 2026
Abstract Full Text PDF[1M]

Managing chronic hypertension requires continuous out-of-clinic blood pressure monitoring. While personal health record (PHR) applications enable longitudinal vital data tracking, their practical application in sharing clinical data with prescribing physicians remains limited. This case report describes a novel pharmacist-led remote monitoring intervention using a PHR application (SaluDi) in an asymptomatic older female in her 60s with hypertension, diabetes mellitus, and dyslipidemia. Despite excellent medication adherence, longitudinal home blood pressure data revealed persistent elevation (systolic blood pressure 130s–140s mmHg), exceeding the updated 2025 guideline target (<125/75 mmHg). The pharmacist submitted a tracing report to the prescribing physician suggesting an amlodipine dose increase (2.5 mg to 5 mg/day). Although the physician considered the adjustment, shared decision making with the patient led to maintaining the current regimen according to her preference and perceived blood pressure stabilization. Pharmacist-led PHR evaluation and data sharing via tracing reports provide an effective framework for interprofessional communication and individualized chronic disease management in primary care settings.

Regular Article
Harmful Element Content and Migration from Metal Accessories That May Be Accidentally Swallowed by Infants and Young Children Vol.9, No.6, p.209-213
Yoko Mori , Tsuyoshi Kawakami , Reiji Kubota , Maiko Tahara , Sachie Kawano , Nahoko Uchiyama
Received: September 11, 2026
Accepted: October 23, 2026
Released: November 06, 2026
Abstract Full Text PDF[721K]

Recent reports from various countries have indicated that metal accessories may contain high levels of harmful elements. Although this is primarily a concern because of the risk of accidental swallowing by infants and young children, information on this issue in Japan remains limited. Therefore, this study aimed to investigate the contents of eight harmful elements (Sb, As, Ba, Cd, Cr, Pb, Hg, and Se) in 47 metal accessories available in Japan that infants and young children might accidentally swallow, and determine the migration of these elements from the accessories. Pb (80–2,600 mg/kg) and Cd (50–660,000 mg/kg) were detected in metal accessories, with some products exceeding the European Union regulatory limits for jewelry articles (Pb: 500 mg/kg; Cd: 100 mg/kg). Cd migration was detected from eight metal accessories with concentrations ranging from 0.99 to 1,100 mg/kg. Two products exceeded the maximum acceptable migration limit of 75 mg/kg specified in ISO 8124-3:2020 “Safety of toys-Part 3: Migration of certain elements.” In contrast, Pb migration was detected in only one product and was less than 10% of the maximum acceptable migration limit. Notably, two products exhibited high Cd migration (390 and 1,100 mg/kg), whereas some products contained high levels of Pb (up to 2,600 mg/kg) and Cd (up to 660,000 mg/kg). These findings highlight the need for continued monitoring of harmful element content and migration from metal accessories, considering not only accidental swallowing but also other exposure routes, such as mouthing behavior.

Report
Diet-induced Differences in the Gut Microbiome and Mycobiome in Conventionally Housed Mice Vol.9, No.6, p.199-208
Kento Takayama , Motoya Miyahara , Nana Morio-Takayama , Mairi Fujikawa , Honoka Ito , Yuka Koike , Kazuyoshi Kawazoe
Received: February 13, 2026
Accepted: October 26, 2026
Released: November 06, 2026
Abstract Full Text PDF[4M]

The human gut hosts diverse microbes essential for metabolism, immune function, and disease prevention. Imbalance, or dysbiosis, of the gut microbiota contributes to various diseases, with diet exerting a stronger influence than genetics. We investigated the effects of five diets, chow, high-carbohydrate, high-fat, high-protein, and high-fiber, on the gut microbiota (bacteria) and mycobiota (fungi) in conventionally housed mice, highlighting implications for pharmaceutical research. Gut microbial composition varied with diet: the phylum Bacillota dominated in the chow, high-carbohydrate, and high-fat diet groups, whereas Bacteroidota predominated in the high-protein and high-fiber diet groups. Linear Discriminant Analysis Effect Size analysis identified distinct bacterial taxa enriched in each dietary group compared with chow. Fungal analysis showed a shift from Ascomycota dominance in chow to Basidiomycota in the other diet groups. Correlation analysis indicated that bacterial–fungal relationships varied with diet; notably, the high-protein diet group showed numerous strong negative correlations between bacterial and fungal families. These findings emphasize that diet shapes microbial composition and interactions in animal models, providing baseline information for considering diet-associated microbial variation in preclinical research.